Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Insect Venom Allergenic Extract [EPC]
Pseudognaphalium Luteoalbum Leaf is a standardized allergenic extract used primarily in the diagnosis and treatment of hypersensitivity to Jersey Cudweed. It belongs to the class of Standardized Insect Venom Allergenic Extracts [EPC] for regulatory and potency standardization purposes.
Name
Pseudognaphalium Luteoalbum Leaf
Raw Name
PSEUDOGNAPHALIUM LUTEOALBUM LEAF
Category
Standardized Insect Venom Allergenic Extract [EPC]
Drug Count
3
Variant Count
3
Last Verified
February 17, 2026
About Pseudognaphalium Luteoalbum Leaf
Pseudognaphalium Luteoalbum Leaf is a standardized allergenic extract used primarily in the diagnosis and treatment of hypersensitivity to Jersey Cudweed. It belongs to the class of Standardized Insect Venom Allergenic Extracts [EPC] for regulatory and potency standardization purposes.
Detailed information about Pseudognaphalium Luteoalbum Leaf
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Pseudognaphalium Luteoalbum Leaf.
Pseudognaphalium Luteoalbum Leaf, commonly known as Jersey Cudweed, is a botanical substance utilized in clinical immunology as a standardized allergenic extract. Within the regulatory framework of the United States Food and Drug Administration (FDA), it is categorized under the class of Standardized Insect Venom Allergenic Extract [EPC]. While the raw material is derived from a plant in the Asteraceae family, its classification alongside insect venoms highlights the rigorous standardization processes required to ensure biological potency and safety in patients undergoing allergen immunotherapy (hyposensitization).
This extract is primarily indicated for use in skin testing (diagnostic) and as part of a subcutaneous immunotherapy (SCIT) regimen for patients who demonstrate a clinically significant IgE-mediated hypersensitivity to Jersey Cudweed pollen or leaf proteins. The goal of using this extract is to modulate the patient's immune system, shifting the response from a Th2-mediated allergic reaction to a more tolerant Th1-mediated response. According to the FDA’s Biologics License Application (BLA) standards, these extracts must maintain consistent levels of major allergens to ensure that clinicians can safely escalate doses during the build-up phase of treatment.
The mechanism of action for Pseudognaphalium Luteoalbum Leaf extract involves complex immunomodulation. When administered in small, controlled doses, the extract interacts with the patient's immune system to induce 'immunological tolerance.' At the molecular level, this is achieved by several pathways:
Unlike traditional small-molecule drugs, the pharmacokinetics of allergenic extracts are not characterized by typical absorption, distribution, metabolism, and excretion (ADME) studies. Because the extract is a complex mixture of proteins and glycoproteins, its 'bioavailability' is measured by its local and systemic immunological impact.
Pseudognaphalium Luteoalbum Leaf extract has two primary clinical applications:
Pseudognaphalium Luteoalbum Leaf is available in several concentrated forms, typically measured in Protein Nitrogen Units (PNU) or Weight/Volume (w/v) ratios:
> Important: Only your healthcare provider can determine if Pseudognaphalium Luteoalbum Leaf is right for your specific condition. Immunotherapy should always be conducted under the supervision of a board-certified allergist or immunologist.
The dosage for Pseudognaphalium Luteoalbum Leaf extract is highly individualized and must be determined by a physician based on the patient's sensitivity levels. There is no 'standard' dose for all patients.
Treatment typically begins with a very low dose of a highly diluted extract (e.g., 0.05 mL of a 1:100,000 w/v dilution). Injections are administered once or twice weekly. The dose is gradually increased (escalated) over a period of 3 to 6 months until a 'maintenance dose' is reached. A typical maintenance dose may range from 0.2 mL to 0.5 mL of a 1:100 or 1:10 w/v concentration.
Once the maintenance dose is achieved, the frequency of injections is decreased to once every 2 to 4 weeks. This phase generally continues for 3 to 5 years to ensure long-term desensitization.
Pseudognaphalium Luteoalbum Leaf extract is generally considered safe for pediatric use in children aged 5 years and older. The dosing schedule for children follows the same escalation principles as adult dosing, though the starting concentration may be even more conservative depending on the child's history of asthma or previous systemic reactions. Pediatric patients must be monitored closely for signs of systemic reactions, as they may have more difficulty communicating early symptoms of anaphylaxis.
No dosage adjustments are typically required for renal impairment, as the extract is composed of biological proteins that do not rely on renal filtration for clearance. However, the patient's overall health must be stable.
No dosage adjustments are required for hepatic impairment.
Caution should be exercised in elderly patients, particularly those with underlying cardiovascular disease. The risk of using epinephrine (the treatment for a severe reaction) in patients with heart disease must be weighed against the benefits of immunotherapy.
If a dose is missed during the build-up phase, the next dose may need to be reduced or the previous dose repeated to maintain safety. If a dose is missed during the maintenance phase by more than 1-2 weeks, the allergist will typically reduce the dose for the next injection and then gradually work back up to the maintenance level. Never attempt to double the dose to 'catch up.'
An 'overdose' in the context of allergenic extracts refers to the administration of a dose that exceeds the patient's current tolerance level. This can result from a clinical error or a sudden increase in the patient's sensitivity (e.g., during peak pollen season).
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or frequency without medical guidance.
Most patients undergoing immunotherapy with Pseudognaphalium Luteoalbum Leaf will experience local reactions at the site of injection. These are generally not dangerous but can be uncomfortable.
> Warning: Stop taking Pseudognaphalium Luteoalbum Leaf and call your doctor immediately or seek emergency care if you experience any of these symptoms of anaphylaxis.
Immunotherapy is generally well-tolerated over long periods. There is no evidence that long-term use of Pseudognaphalium Luteoalbum Leaf extract causes autoimmune disease or organ damage. The most significant long-term 'effect' is the desired reduction in allergic sensitivity. However, some patients may develop 'serum sickness-like' symptoms (joint pain, fever, rash) if they are receiving extremely high doses of foreign proteins, though this is exceedingly rare with modern standardized extracts.
Report any unusual symptoms to your healthcare provider, even if they seem minor at first.
Pseudognaphalium Luteoalbum Leaf extract is a potent biological product. It is intended for use only by physicians experienced in the administration of allergenic extracts and the management of anaphylaxis. Patients must be fully informed of the risks and must be capable of recognizing the early signs of a systemic reaction.
As noted in the side effects section, the FDA requires a Black Box Warning for all standardized allergenic extracts, including those in the Standardized Insect Venom Allergenic Extract [EPC] class. The primary focus is on the risk of anaphylaxis. No patient should receive an injection if they are currently experiencing an acute asthma flare or if their FEV1 (Forced Expiratory Volume) is significantly below their personal best.
Most patients can drive themselves to and from appointments. However, if a patient experiences a systemic reaction or feels lightheaded/fatigued after an injection, they should not operate heavy machinery or drive until symptoms have fully resolved.
Alcohol consumption should be avoided for several hours following an injection. Alcohol can cause vasodilation (widening of blood vessels), which may theoretically increase the rate of allergen absorption and the risk of a reaction.
Immunotherapy can be stopped at any time, but the benefits will likely be lost if the 3-5 year maintenance course is not completed. There is no 'withdrawal' syndrome associated with stopping Pseudognaphalium Luteoalbum Leaf extract, but allergic symptoms will likely return to baseline over several months.
> Important: Discuss all your medical conditions with your healthcare provider before starting Pseudognaphalium Luteoalbum Leaf.
There are few absolute contraindications for drug combinations, but the following are generally avoided due to extreme risk:
There are no direct food interactions with Pseudognaphalium Luteoalbum Leaf extract. However, patients with a 'celery-mugwort-spice' syndrome or sensitivity to other Asteraceae plants (like chamomile or sunflower seeds) should be aware of potential cross-reactivity that could increase their overall 'allergic load' on the day of treatment.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Pseudognaphalium Luteoalbum Leaf extract must NEVER be used in the following circumstances:
These conditions require a careful risk-benefit analysis by the allergist:
Pseudognaphalium Luteoalbum (Jersey Cudweed) is part of the Asteraceae family. Patients who are highly allergic to the following may show cross-sensitivity:
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Pseudognaphalium Luteoalbum Leaf.
It is generally considered safe to continue Pseudognaphalium Luteoalbum Leaf immunotherapy while breastfeeding. The large protein molecules in the extract do not pass into breast milk in any significant quantity, and if they did, they would likely be digested by the infant's stomach. There is no known risk to the nursing infant.
Immunotherapy is highly effective in children and may prevent the development of asthma in children with allergic rhinitis (the 'allergic march'). It is typically not started in children under age 5 because of the difficulty in monitoring for systemic reactions and the requirement for frequent injections.
Patients over age 65 may be at higher risk for complications from immunotherapy due to co-existing cardiovascular disease. The physician must ensure the patient's heart can tolerate the potential 'hit' of a systemic reaction and the subsequent treatment with epinephrine.
There are no specific dosing guidelines for patients with renal impairment. Because the extract consists of naturally occurring proteins, it does not accumulate in the blood in the way that synthetic drugs do.
No adjustments are necessary for patients with liver disease. The liver is not the primary organ for the processing of allergenic proteins administered subcutaneously.
> Important: Special populations require individualized medical assessment and close supervision by an immunology specialist.
Pseudognaphalium Luteoalbum Leaf extract works via Somatic Hypermutation and Class Switch Recombination in B-cells. By providing a low-dose, chronic stimulus, the extract encourages B-cells to switch from producing IgE (allergy) to IgG4 (tolerance). It also acts on Dendritic Cells, inducing them to express higher levels of IL-10, which in turn promotes the development of T-regulatory (Treg) cells. These Tregs actively suppress the allergic inflammation caused by Jersey Cudweed pollen in the respiratory mucosa.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous) |
| Protein Binding | Minimal |
| Half-life | Minutes to Hours (local) |
| Tmax | 1-2 hours (systemic absorption) |
| Metabolism | Proteolysis by tissue enzymes |
| Excretion | Not renally/fecally excreted |
This agent is classified as a Standardized Insect Venom Allergenic Extract [EPC]. This specific regulatory class ensures that the extract meets the same potency standards as high-risk venom extracts, requiring precise measurement of biological activity (usually via ELISA or RAST inhibition assays) rather than just total protein weight.
Common questions about Pseudognaphalium Luteoalbum Leaf
Pseudognaphalium Luteoalbum Leaf extract is primarily used for the diagnosis and treatment of allergic reactions to the Jersey Cudweed plant. In a clinical setting, it is used for skin prick testing to identify if a patient has a specific allergy to this botanical. Once an allergy is confirmed, the extract is used in allergen immunotherapy, also known as allergy shots. This process involves giving the patient gradually increasing amounts of the extract to desensitize their immune system. Over time, this reduces the severity of hay fever, allergic conjunctivitis, and allergic asthma symptoms. It is an effective long-term solution for patients who do not get enough relief from standard allergy medications.
The most frequent side effects are local reactions at the site of the injection, occurring in nearly all patients at some point during treatment. These include redness, itching, and a small amount of swelling or a 'hive' where the needle entered the skin. These symptoms usually appear within minutes and fade within a few hours. Some patients may also experience 'large local reactions,' where the swelling exceeds several inches in diameter. Less commonly, patients might feel slightly fatigued or experience a temporary increase in their typical allergy symptoms like sneezing or a runny nose. Most of these effects are mild and can be managed with over-the-counter antihistamines or ice packs.
It is generally advised to avoid alcohol for several hours before and after receiving an injection of Pseudognaphalium Luteoalbum Leaf extract. Alcohol acts as a vasodilator, meaning it widens the blood vessels and increases blood flow throughout the body. This increased circulation could potentially cause the allergenic proteins in the extract to be absorbed into your system more quickly than intended. Rapid absorption increases the risk of a systemic or 'whole-body' allergic reaction, including the risk of anaphylaxis. For your safety, it is best to wait until the following day to consume alcoholic beverages. Always discuss your lifestyle habits with your allergist to ensure the safest treatment environment.
The safety of starting Pseudognaphalium Luteoalbum Leaf extract during pregnancy has not been established, and it is generally avoided. Doctors typically will not begin the 'build-up' phase of allergy shots for a pregnant patient because of the higher risk of a severe allergic reaction during this time. If a severe reaction occurs, it could lead to a lack of oxygen for the developing fetus. However, if a woman is already on a stable maintenance dose and then becomes pregnant, most allergists agree that it is safe to continue the treatment. The dose is usually kept the same or slightly reduced, but never increased until after delivery. Always inform your doctor immediately if you become pregnant while receiving immunotherapy.
Immunotherapy with Pseudognaphalium Luteoalbum Leaf is a long-term commitment and does not provide immediate relief like an antihistamine. Most patients do not notice a significant improvement in their allergy symptoms until they have reached their maintenance dose, which usually takes 3 to 6 months. Substantial clinical benefits are typically observed after the first full year of treatment. To achieve long-lasting or permanent relief, the treatment must usually be continued for 3 to 5 years. If you do not see any improvement after a year of maintenance therapy, your doctor may re-evaluate the treatment plan or check for other underlying allergies. Consistency with your injection schedule is key to seeing results.
Yes, you can stop taking Pseudognaphalium Luteoalbum Leaf injections suddenly without experiencing any physical withdrawal symptoms. Unlike some medications that affect the nervous system, allergenic extracts are biological proteins that do not cause dependency. However, if you stop the treatment before completing the recommended 3-to-5-year course, your allergy symptoms are very likely to return. The immune system requires long-term exposure to the extract to 'learn' to be tolerant of the allergen. If you need to pause your treatment due to illness or travel, your doctor will provide a schedule to safely restart at a lower dose. Always consult your allergist before deciding to discontinue your immunotherapy.
If you miss a scheduled injection of Pseudognaphalium Luteoalbum Leaf, you should contact your allergist's office as soon as possible to reschedule. Do not simply wait for your next regular appointment. The safety of the next dose depends on the time interval since your last injection. If you are in the build-up phase and miss a dose, your doctor may need to repeat the previous dose or even reduce it to ensure you don't have a reaction. If you are in the maintenance phase and miss a dose by more than a week or two, a temporary dose reduction is often necessary. Never attempt to administer the extract yourself or take a double dose to make up for the one you missed.
There is no clinical evidence to suggest that Pseudognaphalium Luteoalbum Leaf extract causes weight gain. The extract consists of proteins and stabilizers administered in very small volumes (usually less than 0.5 mL). It does not contain hormones, steroids, or calories that would impact your metabolism or body weight. If you experience weight changes while on immunotherapy, it is likely due to other factors, such as lifestyle changes, other medications (like oral corticosteroids sometimes used for severe allergies), or an unrelated medical condition. If you have concerns about your weight, you should discuss them with your primary care physician, but you can be confident it is not a side effect of the allergy shots.
Pseudognaphalium Luteoalbum Leaf can be taken alongside most common medications, but there are some very important exceptions. You must tell your doctor if you are taking beta-blockers, which are often prescribed for high blood pressure or heart conditions, as they can make it difficult to treat a severe allergic reaction. ACE inhibitors and MAO inhibitors also require special caution. Most standard allergy medications, like antihistamines and nasal sprays, are fine to continue, though your doctor might ask you to avoid them on the day of a skin test. Always provide your allergist with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you use to ensure there are no dangerous interactions.
Allergenic extracts like Pseudognaphalium Luteoalbum Leaf are biological products rather than simple chemical drugs, so the term 'generic' does not apply in the traditional sense. Instead, different manufacturers may produce their own versions of the extract under various brand names. These are often referred to as 'biosimilars' in other contexts, but in the world of allergy, they are simply different brands of the same standardized extract. While the active ingredient—the Jersey Cudweed protein—is the same, the concentration and stabilizers might vary slightly between manufacturers. Your allergist will typically stick with one reliable supplier for your entire course of treatment to ensure consistency in your dosing.